Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats

Figure 1 Glucagon-like peptide-2 protects impaired intestinal mucosa on day 14. A: Mesentery anatomy of the three groups; B: Body weights of the rats in three groups on day 14; C: Wet intestinal weights of the rats in the three groups on day 14. ^aP < 0.05 vs control, ^cP < 0.05, ^dP < 0.01, OB vs OBGLP-2;. C: Control; OB: Obstructive jaundice; OBGLP-2: Obstructive jaundice with GLP-2.

Figure 2 Intestinal mucosal pathological alterations as assessed by HE staining and sIgA immunohistochemical appearance on day 14. C: Control; OB: Obstructive jaundice; OBGLP-2: Obstructive jaundice with GLP-2.

Figure 3 Comparison of serum alanine aminotransferase (A), total bilirubin (B) and endotoxin levels (C) in three groups (n = 12). ^aP < 0.05, ^bP < 0.01, OB vs OBGLP-2. C: Control; OB: Obstructive jaundice; OBGLP-2: Obstructive jaundice with GLP-2.